Advertisement

Topics

Latest "BioTechNews Denmark" News Stories

05:36 EDT 20th October 2018 | BioPortfolio

Here are the most relevant search results for "BioTechNews Denmark" found in our extensive news archives from over 250 global news sources.

More Information about BioTechNews Denmark on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about BioTechNews Denmark for you to read. Along with our medical data and news we also list BioTechNews Denmark Clinical Trials, which are updated daily. BioPortfolio also has a large database of BioTechNews Denmark Companies for you to search.

Showing "BioTechNews Denmark" News Articles 1–25 of 585

Saturday 20th October 2018

Another Looming Maternal Risk Associated with Preeclampsia?

Investigators in Denmark discovered a striking relation between preeclampsia and excess risk for subsequent vascular dementia.


Friday 19th October 2018

SynteractHCR Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 12102018] Prices from USD $250

SummarySynteractHCR Inc SynteractHCR a subsidiary of Amulet Capital Partners LP is a contract research organization that offers clinical trials support services. The organization provides phase I IV clinical development services, clinical services, vendor management, study document development, project management, risk mitigation and management, and clinical trial management system. It offers med...

Zeria Pharmaceutical Co Ltd 4559 Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 12102018] Prices from USD $250

SummaryZeria Pharmaceutical Co Ltd Zeria, formerly Zeria Yakusho Kenkyusho Co Ltd is a pharmaceutical company that manufactures pharmaceutical and nonpharmaceuticals, veterinary pharmaceuticals, industrial chemicals and reagents. The company imports and exports healthcare products such as cosmetics, health foods, alcoholic beverages, soft drinks, food additives, livestock feed, hygienic goods, amo...


Agilent Technologies Inc A Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 12102018] Prices from USD $250

SummaryAgilent Technologies Inc Agilent is a provider of instruments, reagents, software, services and consumables for comprehensive laboratory workflow. Its product portfolio comprises atomic absorption systems, bioanalyzers, gene expression microarrays and automation systems, among others. The company serves biotechnology, pharmaceutical, contract research organizations CROs and contract manufac...

Thursday 18th October 2018

Basilea Pharmaceutica Ltd BSLN Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 12102018] Prices from USD $250

SummaryBasilea Pharmaceutica Ltd Basilea is a biopharmaceutical company that develops and markets antibiotics, antifungals and oncology drugs. The company's products address increasing resistance and nonresponse to present treatment options for various therapeutic areas such as cancer, bacterial infections and fungal infections, among others. Basilea also conducts research in the areas of antiinfe...

Apogenix to Present at Five Upcoming International Conferences

DGAP-News: Apogenix AG / Key word(s): Conference 18.10.2018 / 10:00 The issuer is solely responsible for the content of this announcement. Apogenix to Present at Five Upcoming International Conferences Heidelberg, Germany, October 18, 2018 - Apogenix, a biopharmaceutical company developing next generation immuno-oncology therapeutics, announced today that company representatives will a...

Wednesday 17th October 2018

Acadia Pharmaceuticals Inc ACAD Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 24072018] Prices from USD $250

SummaryAcadia Pharmaceuticals Inc Acadia discovers, develops and commercializes small molecule drugs for the treatment of central nervous system disorders. The company's lead product Nuplazid pimavanserin is an FDA approved drug for the treatment of Parkinson's disease psychosis. Acadia also develops pimavanserin for the treatment of Alzheimer's disease agitation and Alzheimer's disease psychosis ...

Brewing Enzymes Market by Type Amylase, Betaglucanase, Protease, Xylanase, ALDC, Pectinase, Application Beer and Wine, Source Microbial and Plant, Form Liquid and Powder, Process, and Region Global Forecast to 2023 [Report Updated: 24072018] Prices from

Brewing enzymes market projected to grow at a CAGR of 6.6% during the forecast period.The brewing enzymes market is estimated at USD 352.1 million in 2018. It is projected to reach USD 484.7 million by 2023, at a CAGR of 6.6% from 2018, in terms of value. The market is driven by the increase in popularity of craft breweries and specialty beers, continuous RDresulting in product and process innovat...

Orion Diagnostica Oy Medical Equipment Deals and Alliances Profile [Report Updated: 07092018] Prices from USD $250

SummaryOrion Diagnostica Oy Orion Diagnostica, a subsidiary of Orion Oyj, is a medical equipment company that develops, manufactures clinical diagnostic and hygiene monitoring tests. Its product portfolio provides diagnosis and treatment management kits, point of care systems, ready to use kits, portable incubators, dipslide culture tests, hygiene tests among others. The company's products find ap...

STERNA BIOLOGICALS TO ATTEND BIO-EUROPE(R) 2018 24th ANNUAL INTERNATIONAL PARTNERING CONFERENCE

DGAP-News: sterna biologicals GmbH & Co. KG / Key word(s): Conference 17.10.2018 / 14:00 The issuer is solely responsible for the content of this announcement. STERNA BIOLOGICALS TO ATTEND BIO-EUROPE(R) 2018 24th ANNUAL INTERNATIONAL PARTNERING CONFERENCE Marburg, Germany, October 17, 2018 - Sterna biologicals GmbH & Co. KG ("sterna"), an innovative clinical-stage immunology compan...

Secarna Pharmaceuticals to attend BIO-Europe(R) 2018 - 24th Annual International Partnering Conference

DGAP-News: Secarna Pharmaceuticals GmbH & Co. KG / Key word(s): Conference 17.10.2018 / 13:00 The issuer is solely responsible for the content of this announcement. Secarna Pharmaceuticals to attend BIO-Europe(R) 2018 - 24th Annual International Partnering Conference Munich/Martinsried, Germany, October 17, 2018 - Secarna Pharmaceuticals ("Secarna"), a new breed biopharmaceutical compa...

IDT Biologika Awarded 10-Year NIH Contract to Manufacture Vaccines and Biologics for Infectious Diseases

IDT Biologika, a globally integrated manufacturer of vaccines and biopharmaceuticals, announced today that the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services, has awarded the company a 10-year Indefinite Quantity, Indefinite Del...

WHOOP, the Human Performance Company, Launches in Europe

Used by the world’s top performers, WHOOP enables consumers to reach their highest potential by better understanding their bodies WHOOP, the human performance company, is now available to European consumers for the first time. Launched in the US in 2014, WHOOP is now shipping to countries throughout Europe via the WHOOP website. Initial countr...

Tuesday 16th October 2018

CMC Biologics AS Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 07092018] Prices from USD $250

SummaryCMC Biologics A/S CMC Biologics, formerly CMC Biopharmaceuticals A/S, a subsidiary of Asahi Glass Co., Ltd., is a contract process development and manufacturer of biopharmaceuticals. The company's service portfolio encompasses process development, cGMP manufacturing, and quality and regulatory services. Its process development services include cell culture development, upstream and downstre...

Brewing Enzymes Market by Type Amylase, Betaglucanase, Protease, Xylanase, ALDC, Pectinase, Application Beer and Wine, Source Microbial and Plant, Form Liquid and Powder, Process, and Region Global Forecast to 2023 [Report Updated: 25072018] Prices from

Brewing enzymes market projected to grow at a CAGR of 6.6% during the forecast period.The brewing enzymes market is estimated at USD 352.1 million in 2018. It is projected to reach USD 484.7 million by 2023, at a CAGR of 6.6% from 2018, in terms of value. The market is driven by the increase in popularity of craft breweries and specialty beers, continuous RDresulting in product and process innovat...

Vertex’s Danish Reimbursement Deal Brings Budget Predictability

Vertex’s portfolio-based access deal in Denmark will give patients quicker access to a range of cystic fibrosis drugs and give...   

Monday 15th October 2018

Global Human Growth Hormone Drugs Market Status and Outlook 20182025 [Report Updated: 14082018] Prices from USD $4000

Report SnapshotKey Content of Chapters Including and can be customized, report is a semifinished version, and it takes 4872 hours to upgradePart 1:Terminology Definition, Industry Chain,Industry Dynamics Regulations and Global Market OverviewPart 2:Upstream Raw Materials / Components Manufacturing Procurement Methods Channels and Cost , Major Regional Production Overview and Trade FlowPart 3:Pr...

CiToxLAB Group Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 13082018] Prices from USD $250

SummaryCiToxLab Group CiToxLab is a contract research organization that provides preclinical and specialty services. The company provides toxicology and safety pharmacology, biomarkers, pharmacokinetics, immunology services, surgical models and medical device implantation, animal efficacy models, preclinical and clinical genomics and biodistribution services. CiToxLab also offers support services ...

ESMO advocacy for patient-centred care takes on global dimension

(European Society for Medical Oncology) Supportive and palliative care should be an integral part of cancer treatment (ESMO Position Paper, 2017). To maintain the spotlight on the topic, on Friday, 19 October, a special session at the ESMO 2018 Congress will be dedicated to this subject and followed on Sunday by the formal recognition of 20 newly-accredited Designated Centres of Integrated Oncolog...

Sunday 14th October 2018

Exiqon AS Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 12092018] Prices from USD $250

SummaryExiqon AS Exiqon, a subsidiary of Qiagen NV, is a medical device company that develops, manufactures and markets molecular diagnostic test products. The company provides product categories such as microRNA research, incRNA research, mRNA research, DNA research, custom oligos and other reagent products, among others. It offers microRNA research products such as RNA isolation kits, microRNA s...

Mediq N.V. Strategy, SWOT and Corporate Finance Report [Report Updated: 28072018] Prices from USD $175

Mediq N.V. Strategy, SWOT and Corporate Finance ReportSummaryMediq N.V. Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360 view of the company.Key HighlightsMediq N.V. Mediq or 'the company' is an internatio...

SynteractHCR Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 17092018] Prices from USD $250

SummarySynteractHCR Inc SynteractHCR a subsidiary of Amulet Capital Partners LP is a contract research organization that offers clinical trials support services. The organization provides phase I IV clinical development services, clinical services, vendor management, study document development, project management, risk mitigation and management, and clinical trial management system. It offers med...

Saturday 13th October 2018

Xellia Pharmaceuticals ApS Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 17092018] Prices from USD $250

SummaryXellia Pharmaceuticals ApS Xellia, a subsidiary of Novo A/S is a healthcare products provider that offers fermented and semisynthetic APIs and injectable finished dosage forms. The company offers strain and fermentation development with bacteria and fungi. It provides injectable products in the form of liquids, aseptically filled dry powders or in the form of freezedried powders; and inhala...

BioVendor Laboratorni Medicina as Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 27082018] Prices from USD $250

SummaryBioVendor Laboratorni Medicina as BioVendor is a developer and manufacturer of immunoassays, recombinant protiens, antibodies and endotoxinremoval products. The company provides products such as immunoassays, proteins, antibodies, endotoxin removal products, endotoxin detection products, immunohistochemistry, cellbased assays and colorimetric assays, among others. Its products are used in ...

Global Phenolic Foam Market Status and Outlook 20182025 [Report Updated: 01082018] Prices from USD $4000

Report SnapshotKey Content of Chapters Including and can be customized, report is a semifinished version, and it takes 4872 hours to upgradePart 1:Terminology Definition, Industry Chain,Industry Dynamics Regulations and Global Market OverviewPart 2:Upstream Raw Materials / Components Manufacturing Procurement Methods Channels and Cost , Major Regional Production Overview and Trade FlowPart 3:Pr...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks